ArticleOne health (Amsterdam, Netherlands)2020
The novel Coronavirus (SARS-CoV-2) is a one health issue.
Article in One health (Amsterdam, Netherlands), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04869579 (Selenium as a Potential Treatment for Moderately-ill, Severely-ill, and Critically-ill COVID-19 Patients), which is not on this map. Cited by 29 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Selenium as a Potential Treatment for Moderately-ill, Severely-ill, and Critically-ill COVID-19 Patients
Who cites it
29 citing papers in PubMed.
- Veterinary student narratives of veterinary and interprofessional identity.Frontiers in medicine · 2026Article
- Article
- Metabolic modeling elucidates phenformin and atpenin A5 as broad-spectrum antiviral drugs against RNA viruses.Communications biology · 2025Article
- Climate change: A health emergency for humans, animals, and the environment.One health (Amsterdam, Netherlands) · 2024Article
- Insights into structural vaccinology harnessed for universal coronavirus vaccine development.Clinical and experimental vaccine research · 2024Review
- Mapping immunological and host receptor binding determinants of SARS-CoV spike protein utilizing the Qubevirus platform.The Journal of biological chemistry · 2023Article
- Identification of novel inhibitors for SARS-CoV-2 as therapeutic options using machine learning-based virtual screening, molecular docking and MD simulation.Frontiers in molecular biosciences · 2023Article
- One (vis-à-vis Planetary, Eco) health: A landscape analysis of educational programs.Public health challenges · 2022Review
- Narrative review on century of respiratory pandemics from Spanish flu to COVID-19 and impact of nanotechnology on COVID-19 diagnosis and immune system boosting.Virology journal · 2022Review
- Evaluation of UVC Excimer Lamp (222 nm) Efficacy for Coronavirus Inactivation in an Animal Model.Viruses · 2022Article
- An occupational risk of hepatitis E virus infection in the workers along the meat supply chains in Guangzhou, China.One health (Amsterdam, Netherlands) · 2022Article
- Article
- Exploring peptide studies related to SARS-CoV to accelerate the development of novel therapeutic and prophylactic solutions against COVID-19.Journal of infection and public health · 2021Review
- Predictability of COVID-19 worldwide lethality using permutation-information theory quantifiers.Results in physics · 2021Article
- Pooling of Nasopharyngeal Swab Samples To Overcome a Global Shortage of Real-Time Reverse Transcription-PCR COVID-19 Test Kits.Journal of clinical microbiology · 2021Article
- One welfare impacts of COVID-19 - A summary of key highlights within the one welfare framework.Applied animal behaviour science · 2021Article
- The Missing Professional Perspective: Medical, Veterinary, and Dual Degree Public Health Student Perceptions of One Health.Frontiers in public health · 2021Article
- Zoonotic spillover: Understanding basic aspects for better prevention.Genetics and molecular biology · 2021Article
- A proposal for testing kit of corona viruses using 3D photonic structure.Microsystem technologies : sensors, actuators, systems integration · 2021Article
- Prevention and control of COVID-19 in pastoral community through One Health Approach.One health (Amsterdam, Netherlands) · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.